ONYX BIOTEC LIMITED Share Price

NSE: ONYX

S Cap

₹ 42.05

-₹2.20 (-4.97%)

Last updated 26 Aug, 2026, 14:24 IST

ONYX BIOTEC LIMITED Share Price Today

As of 26 Aug 2026, ONYX BIOTEC LIMITED share price is ₹42.05. The stock opened at ₹44.40, compared to its previous close of ₹44.25. During today's trading session, ONYX BIOTEC LIMITED share price moved in the range of ₹42.05 to ₹44.40, with an average price of ₹43.22 for the day. Looking at its last 52-week, the stock has touched a low of ₹24.20 and a high of ₹51.00. On the performance front, ONYX BIOTEC LIMITED share price has increased by 30.53% over the last six months and is down 7.81% on a year-on-year basis.

₹42.05

4.97% down today

₹44.40

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 12.34 % in last 1 month

Shareholding Pattern

FIIFII decreased stake by 45.20%

ONYX BIOTEC LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,38,021-₹61,979 (-12.40%)

3 Year

₹3,87,915-₹1,12,085 (-22.42%)

5 Year

₹3,87,915-₹1,12,085 (-22.42%)

₹42.05₹46.45

Circuit Low

Circuit High

₹24.20₹51.00

52-Week Low

52-Week High

Circuit

₹42.05

₹46.45

52-week

₹24.20

₹51.00

About ONYX BIOTEC LIMITED

ISIN

INE0WVU01018

Sector Market Cap

₹ 80.23 Cr

Onyx Biotec Ltd. is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. It develops, manufactures and distributes generic and branded pharmaceutical products in various forms, like water for injection (WFI), dry powder injections, and dry powder syrup. WFI is a sterile preparation of water, which is supplied only in single-dose containers, indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection. Its dry powder injections include Ceftriaxone and Sulbactam for Injection, Cefazoline Sodium for Injection, and Cefepime and Tazobactam for Injection, among others. Its dry powder syrups include Cefpodoxime Proxetil, Cefuroxime Axetil, and others. Its core business is focused on providing end-to-end product development and manufacturing solutions to its clients. Its services also include preparation and filing of regulatory dossiers in the Indian and global markets.

ONYX BIOTEC LIMITED Financial Highlights

Revenue: ONYX BIOTEC LIMITED reported revenue of ₹69.91 crore in FY26 vs ₹63.12 crore in FY25. It showed an increase of 10.76% on a yearly basis.
Operating Profit: ONYX BIOTEC LIMITED reported an operating loss of ₹0.42 crore in FY26 vs ₹6.48 crore in FY25. It showed a decrease of 106.48% on a year-on-year basis.
Net Profit: ONYX BIOTEC LIMITED reported a net loss of ₹0.21 crore in FY26 vs ₹4.95 crore in FY25. It showed a decrease of 104.24% on a yearly basis.

Promoters

65.10%

FII

1.07%

Other DII

2.39%

Retail and other

31.44%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Nov 2024	8.72%
Mar 2025	5.36%
Sep 2025	1.95%
Mar 2026	1.07%

Mkt Cap Cr

80.23

P/E

-368.75

P/B

1.45

ROE

-0.39%

D/E

0.27

ROCE

1.12%

Div. Yield

0.00%

EPS(TTM)

-0.12

Turnover

1.11

EV/EBITDA

0.00

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.00%

Quick Ratio

0.00

Curr. Ratio

2.33

Mkt Cap Cr

80.23

P/E

-368.75

P/B

1.45

ROE

-0.39%

D/E

0.27

ROCE

1.12%

Div. Yield

0.00%

EPS(TTM)

-0.12

Turnover

1.11

EV/EBITDA

0.00

Net Margin

0.00%

Op. Margin

0.00%

ROA

0.00%

Quick Ratio

0.00

Curr. Ratio

2.33

Based on fundamentals, this stock's

Performance

Excellent

Onyx Biotec outperforming all market indices

Valuation

Overvalued

Onyx Biotec appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,58,249.00	37.96	5.50	13.74%	0.61	17.33%	93.24	0.83%	0.48	10.90
Divis Laboratories	2,30,427.00	78.78	13.75	15.32%	0.00	19.56%	629.49	0.35%	0.55	98.19
Torrent Pharmaceuticals	1,84,891.00	86.80	22.25	25.49%	1.69	13.85%	222.76	0.70%	0.49	58.70
Cipla	1,14,715.00	34.18	3.33	11.27%	0.00	14.95%	423.36	0.92%	0.45	43.52
Zydus Lifesciences	1,12,718.00	24.54	4.16	18.59%	0.31	17.35%	237.30	0.09%	0.33	35.38
Lupin	99,448.10	17.92	4.43	23.76%	0.04	24.88%	659.05	0.83%	0.57	129.18
Dr. Reddy's Laboratories	99,409.90	31.23	2.61	11.07%	0.18	12.54%	377.96	0.67%	0.41	38.68
Mankind Pharma	97,756.10	47.28	6.00	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Laurus Labs	1,00,768.00	92.42	19.01	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Aurobindo Pharma	92,247.50	24.86	2.43	9.25%	0.19	11.76%	394.82	0.25%	0.38	41.58

ONYX BIOTEC LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹61.95	₹53.75	₹39.49	₹44.86
Other Income	₹1.17	₹0.13	₹0.12	₹0.12
Total Revenue	₹63.12	₹53.87	₹39.62	₹44.98
Total Expenses	₹56.64	₹49.38	₹37.07	₹41.19
Profit Before Tax	₹6.48	₹4.49	₹2.55	₹3.80
Tax	₹1.52	₹0.86	₹0.70	₹0.44
Profit After Tax	₹4.95	₹3.63	₹1.84	₹3.35
EPS - Basic	₹3.31	₹3.05	₹1.56	₹2.84
EPS - Diluted	₹3.31	₹3.05	₹1.56	₹2.84

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹6.48	₹4.49	₹2.55	₹3.80
Income before WC changes	₹11.08	₹8.55	₹0.36	₹5.94
Change in Assets	-₹12.54	-₹12.98	-₹0.65	-₹8.78
Change in Liabilities	₹2.88	₹5.95	₹2.24	₹3.33
Change in WC	-₹9.66	-₹7.03	₹1.60	-₹5.45
Cash flow from Operations	₹1.42	₹1.52	₹1.96	₹0.49
Cash flow from Investing	₹0.66	-₹3.15	-₹22.67	-₹5.78
Cash flow from Financing	₹5.07	₹3.09	₹16.43	₹5.20
Total Cash Flow	₹7.15	₹1.46	-₹4.29	-₹0.09
Cash (Start of the year)	₹1.47	₹0.01	₹0.01	₹0.11
Cash (End of the year)	₹8.61	₹1.47	-₹4.28	₹0.01

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹42.06	₹44.58	₹44.16	₹22.41
Current Assets	₹49.19	₹29.56	₹14.56	₹14.43
Total Assets	₹91.25	₹74.14	₹58.72	₹36.84
Current Liabilities	₹25.73	₹22.55	₹20.21	₹10.03
Net Current Asset	₹23.46	₹7.01	-₹5.64	₹4.40
Non-Current Liabilities	₹9.90	₹26.30	₹20.31	₹10.43
Equity Capital	₹55.62	₹25.29	₹18.20	₹16.38
Total Equity & Liabilities	₹91.25	₹74.14	₹58.72	₹36.84